How Does a Holter Monitor Help in the Management of Cardiotoxicity?
Early detection of cardiotoxicity is critical in cancer care. By identifying cardiac abnormalities at an early stage, healthcare providers can adjust cancer treatments to mitigate heart damage. This may involve modifying chemotherapy regimens, introducing cardioprotective medications, or referring the patient to a cardiologist for further evaluation and management.
